Combination of hsa-miR-21-3p/ sTNF-RI/ IL12-p40 /CCL25 serves as a promising panel of diagnostic biomarkers for distinguishing malignant from benign nodules in papillary thyroid cancer

Aytatli, Abdulmelik; Şahin, Abdulkadir; Barlak, Neslisah; Caglar, Hasan Onur; Gündoğdu, Betül; Tatar, Arzu; Karatas, Omer Faruk

doi:10.1007/s12020-026-04612-9

Makale Tam Makale Uluslararası 2026 Açık erişimli

Combination of hsa-miR-21-3p/ sTNF-RI/ IL12-p40 /CCL25 serves as a promising panel of diagnostic biomarkers for distinguishing malignant from benign nodules in papillary thyroid cancer

Abdulmelik Aytatli, Abdulkadir Şahin, Neslisah Barlak, Hasan Onur Caglar, Betül Gündoğdu, Arzu Tatar, Omer Faruk Karatas

Endocrine Cilt 91 · Sayı 1 · 27.04.2026

DOI ile aç

Anahtar kelimeler

cytokine Papillary thyroid cancer microRNA miR-21-3p proteome

Atıf için künye

Aytatli, A., Şahin, A., Barlak, N., Caglar, H. O., Gündoğdu, B., Tatar, A., & Karatas, O. F. (2026). Combination of hsa-miR-21-3p/ sTNF-RI/ IL12-p40 /CCL25 serves as a promising panel of diagnostic biomarkers for distinguishing malignant from benign nodules in papillary thyroid cancer. Endocrine, 91(1). https://doi.org/10.1007/s12020-026-04612-9

BibTeX

@article{aytatli2026-217360,
  author = {Aytatli, Abdulmelik and Şahin, Abdulkadir and Barlak, Neslisah and Caglar, Hasan Onur and Gündoğdu, Betül and Tatar, Arzu and Karatas, Omer Faruk},
  title = {Combination of hsa-miR-21-3p/ sTNF-RI/ IL12-p40 /CCL25 serves as a promising panel of diagnostic biomarkers for distinguishing malignant from benign nodules in papillary thyroid cancer},
  journal = {Endocrine},
  year = {2026},
  volume = {91},
  number = {1},
  issn = {1559-0100},
  doi = {10.1007/s12020-026-04612-9},
  url = {https://akademik.atauni.edu.tr/yayinlar/217360-combination-of-hsa-mir-21-3p-stnf-ri-il12-p40-ccl25-serves-as-a-promising-panel}
}